| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance. | ||||
| US8415337 | RECORDATI RARE | Ibuprofen compositions and methods of making same |
Mar, 2032
(8 years from now) | |
Neoprofen is owned by Recordati Rare.
Neoprofen contains Ibuprofen Lysine.
Neoprofen has a total of 1 drug patent out of which 0 drug patents have expired.
Neoprofen was authorised for market use on 13 April, 2006.
Neoprofen is available in injectable;intravenous dosage forms.
The generics of Neoprofen are possible to be released after 02 March, 2032.
Drugs and Companies using IBUPROFEN LYSINE ingredient
Market Authorisation Date: 13 April, 2006
Treatment: NA
Dosage: INJECTABLE;INTRAVENOUS
How can I launch a generic of NEOPROFEN before it's drug patent expiration?
More Information on Dosage
NEOPROFEN family patents
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic